NCT01972724View on ClinicalTrials.gov

Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 16, 2013

Primary Completion Date

October 17, 2016

Study Completion Date

October 17, 2016

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

Pioglitazone

Pioglitazone tablets

DRUG

Metformin

Metformin as prescribed in clinical practice

DRUG

Sulfonylurea

Sulfonylurea as prescribed in clinical practice

Trial Locations (9)

Unknown

Chagwon

Daegu

Daejeon

Gwangju

Gyeonggi-do

Jeonju

Seoul

Ulsan

Wŏnju

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01972724 - Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy | Biotech Hunter | Biotech Hunter